Navigation Links
Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
Date:10/21/2008

CALGARY, Oct. 21 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 7th Annual BIO Investor Forum 2008 on Wednesday, October 29, 2008 at 2:15 p.m. PT. The conference will be held at the Palace Hotel in San Francisco from October 29-31, 2008.

A live audio link to the webcast presentation is available at: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ONC.TO&item_id=1996001, or on the company's website at http://www.oncolyticsbiotech.com. It is recommended that listeners log on 15 minutes in advance of the presentation to register and download any necessary software.

An audio replay will be accessible approximately one hour following the presentation on the Oncolytics website.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

The presentation and webcast times are subject to change. This release and the presentation related thereto contain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control and which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or expectations implied by these forward-looking statemen
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes
2. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
3. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
4. Cell Therapeutics Provides Details on Investor & Media Day to be Held in Milan, Italy on Friday, October 3, 2008
5. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
6. U.S. News Media Group Releases 19th Edition of Americas Best Hospitals
7. VIDEO from Medialink and Med-El: New Technology is Music to Peoples Ears
8. BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
9. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
10. Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
11. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...,theNasdaqStockMarketthattradinginthecompany,scomm...25-NSEwillbefiledwiththe,SecuritiesandExchangeComm...ingonNasdaq,unlessthecompanyfilesanappealtotheNasd...chanappeal,which,willstaythesuspensionanddelisting...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...tday"motionsbytheU.S.BankruptcyCourtfortheDistrict...ledavoluntarypetitionfor,reliefunderChapter11ofthe... , TheordersissuedbytheBankruptcyCourtallowth...apter11proceedings.Inparticular,the,companyreceive...
(Date:11/24/2009)...sia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood...igationalnewdrugapplication(IND)foritsoralinsulinp...eatdiabetes.ThisIND,approvalallowsBiolaxytoinitiat...sordercharacteristicofhighbloodglucoseandpoor,meta...remicro-and,macro-vasculardiseases,lossofvision,ki...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
...cus Therapeutics,(Nasdaq: FOLD ), a biopharmaceut...nistered pharmacological chaperones for the treatm...d quarter 2008 financial results after,the regular... results,announcement will be followed by a live c.... EDT., Interested participants and investors may...
...ultiple Markets, Including Industrial ... 31 PURE Bioscience (Nasdaq:,PURE) today announce...distribution of PURE,s silver dihydrogen citrate (...TM) brand., (Logo: http://www.newscom.com/cgi-bi...nal Inc, a Minneapolis based chemical manufacturer...
...utlook, MELVILLE, N.Y., July 31 Gentiva Health,S...ng provider of,comprehensive home health services,... by double-digit increases in Medicare revenues an..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...he quarter ended June 29, 2008 included:, -- A 13...
Other Biology Technology:Amicus Therapeutics Announces Second Quarter 2008 Results Release Date 2PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 2PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 3PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 4Gentiva Reports Strong Second Quarter led by Home Health Segment 2Gentiva Reports Strong Second Quarter led by Home Health Segment 3Gentiva Reports Strong Second Quarter led by Home Health Segment 4Gentiva Reports Strong Second Quarter led by Home Health Segment 5Gentiva Reports Strong Second Quarter led by Home Health Segment 6Gentiva Reports Strong Second Quarter led by Home Health Segment 7Gentiva Reports Strong Second Quarter led by Home Health Segment 8Gentiva Reports Strong Second Quarter led by Home Health Segment 9Gentiva Reports Strong Second Quarter led by Home Health Segment 10Gentiva Reports Strong Second Quarter led by Home Health Segment 11Gentiva Reports Strong Second Quarter led by Home Health Segment 12
(Date:11/23/2009)...producing some of the highest resolution images of...s have a deeper understanding how biomolecules man...d to a new treatment for kidney stones using biomo...v. 23 online edition of the journal Proceedings o...peptides interact with mineral surfaces by acceler...
(Date:11/23/2009)... new study by University of Alabama at Birmingham ... and co-existing medical conditions (co-morbidity)...ong African-Americans compared to Caucasians who a...ne Nov. 23 in Cancer , a journal of the American ...hough BMI and co-morbidity are independent predict...
(Date:11/23/2009)...w studies reveal in unprecedented detail how the r... new proteins and guide them toward their destinat...r dynamics flexible fitting (MDFF) to examine the ...ecular partners. , The first study, in Proceed...s the intimate signaling between the ribosome and ...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 1Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 2Liberty Screening Hires Top Sales Exec for Southeastern U S 56086 1Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2
...ted to increase usability and adoption of SMS and ...cations, MENLO PARK, Calif., Sept. 10 Promptu Sy...ve voice-powered mobile,applications, unveiled tod...and highly accurate voice dictation system. Using ...ognition (CSSR(TM)) technology, the system convert...
... on the Market, Stantum,s SMK Series Will Let Vend...e Multi-Touch Applications, SAN DIEGO, Sept. 23 ... pioneer developer of multi-touch sensing,technolo...pment board based,on its patented PMatrix(TM) resi...ultaneously move an unlimited number of fingers, n...
... Stevens Institute of Technology has been awarded... to support research and development into biomass ...warded by the DOE to various higher-education inst...ts. In total, the DOE will invest up to $4.4 milli... into how non-food feedstocks can be transformed i...
Other Biology News:Promptu Unveils High Accuracy Voice-to-Text Dictation for Mobile Phones at CTIA 2Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology 2Stevens awarded $1M for advanced biofuels research 2
...mid-Based Deletion Machine is based on the simple,...developed by Goryshin and Reznikoff, and by York e...ns and inversions by intramolecular transposition ... plasmid vector. Although most researchers will be...
...romStreptomyces griseolusthat inhibits protein syn...tivity in eukaryote ribosomes. Reported to induce ...cytic leukemia cells, Jurkat cells, ventricular my...intracellular signals and immediate early gene ind...
VersArray Hybridization Chamber from Bio-Rad
...e-of-the-art separation system using the asymmetri...The Eclipse integrates easily with Wyatts multi-an...iDAWN Tristar, as well as the Optilab DSP. The com... distributions of the particles/molecules separate...
Biology Products: